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The implant-bone interface is the scene of competition between microorganisms and distinct types 
of tissue cells. In the past, various strategies have been followed to support bony integration and to 
prevent bacterial implant-associated infections. In the present study we investigated the biological 
properties of diamond-like carbon (DLC) surfaces containing silver nanoparticles. DLC is a promising 
material for the modification of medical implants providing high mechanical and chemical stability 
and a high degree of biocompatibility. DLC surface modifications with varying silver concentrations 
were generated on medical-grade titanium discs, using plasma immersion ion implantation-induced 
densification of silver nanoparticle-containing polyvinylpyrrolidone polymer solutions. Immersion 
of implants in aqueous liquids resulted in a rapid silver release reducing the growth of surface-bound 
and planktonic Staphylococcus aureus and Staphylococcus epidermidis. Due to the fast and transient 
release of silver ions from the modified implants, the surfaces became biocompatible, ensuring growth 
of mammalian cells. Human endothelial cells retained their cellular differentiation as indicated by the 
intracellular formation of Weibel-Palade bodies and a high responsiveness towards histamine. Our 
findings indicate that the integration of silver nanoparticles into DLC prevents bacterial colonization 
due to a fast initial release of silver ions, facilitating the growth of silver susceptible mammalian cells 
subsequently.
Nanostructured or soft-compound coated surfaces have been successfully tested for cell engineering processes 
and proposed as biointerfaces in the past. Deposition of vascular endothelial cell growth factor (VEGF) or nan-
opattering of the implant surface were shown to promote the growth of particular cell types such as osteoblasts 
and endothelial cells1,2. While osteoblasts are responsible for bone mineralization, endothelial cells form the 
inner part of blood vessels providing oxygen and nutrients to the emerging tissue3–5. Although those intelligent 
implants could be perfectly suited to control the growth of cells they might be less resistant to mechanical stress 
and thus inadequate for implants replacing joints. In this context, coatings of implant surfaces with amorphous, 
diamond-like carbon (DLC) received considerable attention in the past due to their superior mechanical proper-
ties6, superior biocompatibility towards mammalian cells7 and superior stability regarding wear8.
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However, and unfortunately, also bacteria such as Staphylococcus epidermidis are able to colonize DLC sur-
faces9. S. epidermidis and also S. aureus are able to infect the surgical site during insertion of biomaterials asso-
ciated with a high risk of life-threatening bacteraemia10. Therefore, the prophylactic treatment with systemic 
given antibiotics prior to the surgery is still recommended11. However, the formation of biofilms and resistant 
bacteria against antibiotics complicate the treatment of the affected patients dramatically12. This fact, forces the 
development of new materials for joint implants with innovative and effective antimicrobial strategies combined 
with high mechanical strength. In the past, several approaches have been followed to further improve the surface 
properties of DLC coatings in term of biocompatibility or to circumvent bacterial colonization. These include 
modifications with polytetrafluoroethylene (ptfe) providing bacterial repellent properties9,13, integration of tita-
nium dioxide nanoparticles14 or doping with Silicon15. Hybrid surfaces containing silver were also shown to 
significantly reduce the adhesion of S. epidermidis16. Silver and silver nanoparticles are known to exert a high 
antimicrobial activity and have been employed for decades17–19. Nanocrystalline silver is currently investigated 
in several aspects ranging from wound healing20 to waste water treatment21. In contrast to resistances against 
antibiotics, microbes are largely lacking the potential to develop a silver resistance making it an ideal agent to con-
trol infection of bacterial strains such as S. aureus, prone to develop antibiotic resistances22. However, the broad 
antimicrobial effect of silver is potential harmful for the treated patient requiring the profound investigation of 
silver-mediated toxicity towards mammalian organisms23.
In the present study, we investigated novel intelligent hybrid implant surfaces composed of silver nanoparti-
cles embedded within a DLC matrix. The aim of our study was the design of a surface characterized by a tempo-
rary release of reactive silver-ions (silver-burst) providing an antimicrobial activity and subsequently, after that 
silver burst, an excellent mammalian cell compatible surface.
Results and Discussion
Physical surface characterization. Silver nanoparticle-containing DLC was produced on corun-
dum-blasted medical grade Ti6Al4V by a three-step method including wet-chemical particle formation, 
dip-coating and polymer-to-DLC-transformation by plasma immersion ion implantation. Transmission electron 
micrograph (TEM) of a dispersion, containing silver nanoparticle is shown in Fig. 1a. The distribution of the 
particle diameter is given in the inset of Fig. 1a.
The thickness of the DLC coating was determined to be 60 ± 5 nm. Energy dispersive X-ray spectroscopy 
(EDX) mappings of the surface showed that the silver nanoparticles are present all over the surface, but with 
higher density on the sharp features of the rough titanium-blasted surface (Supplementary Fig. S1).
The chemical composition and density of the coatings are given in Table S1, as determined by Rutherford 
backscattering spectroscopy (RBS) and elastic recoil detection analysis (ERDA). As the table shows, layer density 
and hydrogen content are comparable to commonly deposited a-C:H6 and very similar in the different coatings, 
regardless of their silver content. The observed atomic percentages of silver in the coatings are also reflected by 
the initial molar ratios of silver nitrate (AgNO3) and polyvinylpyrrolidone (PVP) in the dispersions. Silver con-
centrations were defined by the ratio of PVP and AgNO3 during the preparation process. Highest achieved silver 
content within the DLC surface modification was 7.0 ± 0.5% (Ag:PVP ratio = 1:1; sample set A), lowest tested 
silver content was 0.9 ± 0.2% (Ag:PVP = 1:20; sample set D). Moreover, we investigated DLC surfaces with inter-
mediate silver concentrations of 4.5 ± 0.5% (Ag:PVP = 1:2; sample set B) and 1.7 ± 0.4% (Ag:PVP = 1:10; sample 
set C). Due to its instability, not all experiments have been conducted on Ag:PVP 1:1 samples. Investigation of the 
bonding structure with Raman spectroscopy showed the typical D and G bonds of a-C:H (Fig. 1b). The intensity 
ratios of these two signals I(D)/I(G), obtained by fitting Gaussian functions, give estimated sp3-ratios of about 
30%, which is also typical for a-C:H24,25. The nano hardness tests gave a hardness of 13.6 ± 3.8 GPa, which is a 
good value for a-C:H. Note that a very low indentation force of 1 mN had to be used in order to keep indentation 
depths under 10% of the total layer thickness, which leads to a relatively high margin of error here. An overview 
of all determined physical properties, which were independent of the silver concentration in the coatings is pre-
sented in Table S2, indicating the successful creation of a-C:H layers on Ti6Al4V substrates.
Antimicrobial activity of implant surfaces. To investigate the antimicrobial properties of modi-
fied implant surfaces by silver nanoparticles integrated into a DLC layer, we selected two bacterial species, 
Staphylococcus aureus and Staphylococcus epidermidis. Both types of bacteria are prove to determine implant 
infections with a high prevalence26. The here tested strains were clinical isolates from previously affected patients, 
e.g. S. epidermidis (Catheter sepsis) and delivered from the ATCC biological resource centre and are thus appro-
priate to assess the antimicrobial properties of implant specimens27.
To this end, we analyzed the growth of S. epidermidis and S. aureus on specimen surfaces (surface-bound) and 
in the supernatant (planktonic form in suspension). In comparison to silver-free specimens (sample set R) and 
DLC-coated surfaces, we found a significantly reduced growth of surface-bound S. aureus and S. epidermidis on 
specimens containing high silver concentrations at 4.5% (sample set B) 24 h after inoculation (Fig. 2a,b). In line 
with this finding we detected a reduced bacterial growth in the corresponding supernatant, suggesting a release of 
sufficient antibacterial amounts of silver into the bacterial suspension (Fig. 2a,b). We measured a dose-dependent 
relationship between the bactericidal properties of the specimens and the silver content. Growth of S. epidermidis 
was even reduced on surfaces containing only 0.9% silver (sample set D, Fig. 2a). Although S. aureus exhibited 
a higher level of silver tolerance in comparison to S. epidermidis, we could provide clear evidence that our silver 
nanoparticle-containing DLC coatings have antimicrobial properties. Silver susceptibility of microbes depends on 
species- or even strain-specific mechanisms reflecting variations in metabolizing silver or repairing silver-related 
cell damages. Antimicrobial properties of silver and silver nanocomposites towards many different microbes 
including also methicillin-resistant S. aureus (MRSA) have been well documented by others28–31. Interestingly, the 
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acting molecular mechanisms of silver toxicity are complex and not limited to specific pathways offering therefore 
a broader antimicrobial profile and virtually no bacterial resistance in contrast to antibiotics31,32.
In previous studies we and others found a high cytotoxicity of silver and silver nanoparticles not only towards 
bacteria but also towards individual mammalian cells32–34 and the whole mammalian organism23. To further 
understand the cytotoxic properties of our implant modifications we next investigated growth of primary osteo-
blasts, endothelial cells and fibroblasts on silver-containing DLC.
Silver-dependent cell growth on implant surfaces. We measured the toxicity of DLC surfaces with 
and without silver nanoparticles towards the mouse fibroblast-like cell line L929, primary human osteoblasts and 
primary human endothelial cells isolated form the umbilical cord vein (HUVEC).
Cellular viability was analyzed by WST-1 assay measuring the mitochondrial activity and thus metabolic activ-
ity of the cells (Fig. 3a). In preliminary experiments we verified the functionality of the WST-1 assay by compar-
ative measurements of the intracellular ATP levels, of the cellular morphology and of the cellular DNA content 
(data not shown).
On native DLC coatings without incorporated silver (sample set R), we found that all tested cell types exhibit 
a high viability similar to cells cultivated on tissue-culture-treated polystyrene (co) (Fig. 3a). This finding is in 
accordance with former studies showing a high biocompatibility of DLC35. Growth inhibition of primary oste-
oblasts and HUVEC was only apparent on surfaces containing 4.5% silver (sample set B) while their metabolic 
activity was not significantly diminished on implant surfaces containing less silver. In contrast, L929 cells are 
more sensitive to silver since they grow already less on DLC containing only 0.9% silver (sample set D) (Fig. 3a).
Although we detected a comparable high resistance of HUVEC and osteoblasts towards silver-enriched 
DLC-coatings, our data clearly indicate that antimicrobial active coatings convey also a potentially unfavourable 
high toxicity toward mammalian cells32. To further distinguish the effect of silver ions and the DLC-surface prop-
erties on cell growth we analyzed the cellular metabolism in the presence of dissolved silver ions.
Figure 1. Physicochemical characterization of silver nanoparticles and DLC. (a) TEM image of silver 
particles in dispersion and particle size distribution determined from several images (inset). Scale bar 
corresponds to 50 nm. (b) Raman spectrum of PVP:Ag 1:2 sample, showing characteristic a-C:H signals.  
D stands for the breathing mode of six-fold rings (disorder) while G stands for the stretching mode of sp2-bonds.
www.nature.com/scientificreports/
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Silver tolerance of mammalian cells. We measured the toxicity of silver nitrate towards the mouse 
fibroblast-like cell line L929, the human monocytic cell line THP-1, the osteoblast-like cell line SAOS-2 and 
HUVEC. THP-1 cells exhibit the lowest tolerance towards silver nitrate, since no measurable metabolism was 
apparent at concentrations of 10 μM. In contrast L929, SAOS-2 cells and HUVEC tolerate more than 10 μM 
AgNO3 (Fig. 3b). The experiments showed that except for the THP-1 cells, all other tested cell lines exhibit a very 
comparable silver tolerance.
Energy dispersive x-ray spectroscopy (EDX) mapping and raster electron microscopy (REM) (Supplementary 
Fig. S1) revealed a rough but homogeneous pattering of the surface regarding its chemical composition and its 
topography. Previous investigations of mammalian cell growth such as osteoblasts, endothelial or endothelial 
progenitor cells on scaffolds suggest a strong linkage between surface pattern36,37, surface properties38, and growth 
behaviour39 and might explain the striking difference between the cellular growth on silver nanoparticle enriched 
DLC-specimens (Fig. 3a) and cellular growth in the presence of dissolved silver ions (Fig. 3b).
Growth behaviour on the implant surface. Next, we applied scatter light-free structured illumination 
fluorescence microscopy (ApoTome), to investigate endothelial cell-specific morphology and cell integrity on 
DLC and DLC with silver in all three spatial dimensions. HUVEC were able to form cell clusters on the implant 
surface within the first 24 hour after seeding (Fig. 4) while a confluent cell layer developed within 7 days of cul-
tivation (Supplementary Fig. S2). DLC-coated implants but not titanium surfaces are characterized by a strong 
green autofluorescence signal (525 ± 20 nm) upon excitation with light of a wavelength of 470 ± 20 nm (green 
structures, Fig. 4). To evaluate the differentiation status of the HUVEC we stained von Willebrand Factor (VWF) 
by immunofluorescence (red vesicles, Fig. 4). VWF plays a pivotal role in coagulation and inflammation and is 
therefore required for wound healing and tissue reconstruction40. VWF is stored in a ready releasable pool of large 
vesicles (Weibel-Palade-Bodies, WPB) within the endothelial cells and is co-released with a bulk of other factors 
comprising proangiogenic factors such as angiopoietin-241. Therefore, the existence of VWF can be regarded as 
marker for endothelial cell functionality and its release as an initial event during wound healing crucial for the 
integration of implants into the bone tissue.
Analysis of endothelial cell functionality. To further understand the potency of endothelial cells for 
the regeneration of the injured bone tissue, we quantified the amount of endothelial-derived VWF secreted by 
HUVEC into the cell supernatant upon treatment with silver nitrate (Fig. 5a) or upon cultivation on implant 
surfaces (Fig. 5b). Stimulation with 50 μM histamine served as a positive control mediating a maximum of VWF 
Figure 2. Antimicrobial activity of surface-modified implant specimens. Growth of planktonic and surface-
bound S. epidermidis (a) and S. aureus (b) in the presence of indicated implant specimens. Concentration of 
bacteria is given as colony forming unit (CFU) and was measured 24 after inoculation with 105 CFU/ml. Data 
are represented as mean ± SD of 16 independent experiments. Statistical significant difference (P < 0.05) is 
indicated by the asterisk. Ti = Ti6Al4V alloy; R = Ti6Al4V alloy with diamond-like carbon (DLC); B = DLC 
with 4.5 ± 0.5% silver; C = DLC with 1.7 ± 0.4% silver; D = DLC with 0.9 ± 0.2% silver.
www.nature.com/scientificreports/
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exocytosis42. High concentrations of silver nitrate (100 μM) induced a strong release of VWF already 15 minutes 
after treatment. In contrast, we measured only a moderate increase of the VWF concentration in the supernatant 
after 4 h upon stimulation with low doses of silver (10 μM). In a previous study we have investigated the release 
of VWF from deceased or dying endothelial cells suggesting a correlation between the accumulation of VWF in 
the cellular supernatant and the reduction of the endothelial membrane integrity43. The fast and strong exudation 
of VWF upon high and toxic silver nitrate concentrations is thus likely related to the loss of the endothelial cell 
viability. However, the moderate release of VWF upon treatment with low concentrations of silver might point 
towards a controlled stimulation of HUVEC, a conclusion that is further underlined by the fact that at this low 
silver concentration also the proliferation was neither significantly increased nor decreased (Fig. 3b).
To measure the available amount of VWF stored within the cells cultivated on implants, we induced a maxi-
mal WPB exocytosis and thereby the acute release of its content through the treatment with histamine. As shown 
in Fig. 5b, a three-fold increase in the amount of VWF was detectable in the supernatants of cells cultivated on 
DLC-surface modifications with silver (sample sets C and D) when compared to pure titanium or DLC without 
silver (sample set R). These findings suggest an increased availability of VWF on DLC enriched with silver nano-
particles either due to an increased expression or a facilitated release.
To clarify whether silver affects the cell cycle and therefore the production of VWF, we correlated the DNA 
content per cell with the amount of VWF secreted into the cellular supernatant. Supplementary Fig. S3a,d indi-
cate a linear connection between the release of VWF and the average cellular DNA content after treatment with 
silver nitrate or upon growth on the implants, suggesting a linkage between the cell cycle and the availability 
of VWF. In contrast, no such relationship was evident for the proinflammatory cytokine interleukin 6 (IL-6) 
(Supplementary Fig. S3b,c). Interestingly, nanocrystalline silver was found to have anti-inflammatory as well as 
Figure 3. Evaluation of the metabolic activity of mammalian cells cultivated in the presence of silver. 
(a) L929 cells, primary osteoblasts and HUVEC were cultivated on different implants, while the metabolic 
activity was measured 24 h after seeding. The metabolic activity of cells grown on tissue culture-treated 
polystyrene (Co) was normalised to 100%, background levels of absorbance were subtracted. The silver content 
of the DLC is indicated in percentage. (b) Dose-dependent effect of silver nitrate (concentrations range from 
0.1 to 1000 μM AgNO3) on the metabolism of L929, THP-1, SAOS-2 and HUVEC. Metabolic activity of non-
treated cells was normalised to 100%, background levels of absorbance were subtracted. Data are represented 
as mean ± SD of at least 3 independent experiments. Statistical significant differences (P < 0.01) to the control 
group (co) are indicated by an asterisk. Ti = Ti6Al4V alloy; R = Ti6Al4V alloy with diamond-like carbon 
(DLC); B = DLC with 4.5 ± 0.5% silver; C = DLC with 1.7 ± 0.4% silver; D = DLC with 0.9 ± 0.2% silver.
www.nature.com/scientificreports/
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Figure 4. Analysis of endothelial cell growth on implant surfaces. Three-dimensional images of HUVEC 
grown on titanium (Ti), DLC (sample set R), DLC with 0.9% silver (sample set D) and DLC with 1.7% silver 
(sample set C). The endothelial cell marker von Willebrand factor (VWF) was stained in red. Nuclei were 
stained with DAPI (blue). DLC surfaces of implants are represented in green. White scale bars correspond to 
10 μm.
Figure 5. Analysis of VWF exocytosis. (a) Release of von Willebrand factor (VWF) after treatment with silver 
nitrate (10 μM and 100 μM) for 15 min (black bars) or 4 h (white bars). Co = tissue culture-treated polystyrene; 
hist. = 50μM histamine. (b) Release of VWF from HUVEC grown on implants. VWF release was induced by 
stimulation with 50μM histamine as positive control. The silver content of the DLC surfaces is indicated in 
percentage. (c) Relative average tube length of HUVEC in the presence of different silver nitrate concentrations 
(AgNO3) and VEGF-A (50 ng/ml) as a positive control. Representative images showing the tube formation 
capacity of HUVEC are depicted. Scale bar corresponds to 100 μm. Data are represented as mean ± SD of 
at least 3 independent experiments. Statistical significant differences (P < 0.01) to the control group (co) or 
titanium surfaces (Ti) are indicated by an asterisk. Ti = Ti6Al4V alloy; R = Ti6Al4V alloy with diamond-like 
carbon (DLC); B = DLC with 4.5 ± 0.5% silver; C = DLC with 1.7 ± 0.4% silver; D = DLC with 0.9 ± 0.2% silver.
www.nature.com/scientificreports/
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pro-healing properties during skin regeneration after wounding or inflammatory diseases44,45 probably through 
the upregulation of growth factors46.
Our data provide clear evidence for a physiological growth, differentiation and functionality of endothelial 
cells cultivated on silver-containing implant coatings, while non-toxic concentrations of silver appears to even 
support a proangiogenic phenotype as indicated by an increased release of VWF. A tube formation assay could 
further prove this notion, since we found a clearly increased average tube length at low doses of silver nitrate 
(16μM) similar to that induced by recombinant vascular endothelial growth factor (VEGF). Only extremely high 
concentrations of silver (256 μM) could completely block the formation of tubes (Fig. 5c). Activation of endothe-
lial cells and angiogenesis is fundamental for the proper wound healing and thus a key event during the bony 
integration of the implant. However, to allow colonization also of cells with a lower silver tolerance, a fast and 
complete release of silver from the DLC surface would be desired. To address this aspect, we analyzed the silver 
release kinetics of the DLC-silver implant surfaces in the next set of experiments.
Silver release kinetics. Although endothelial cells resist comparable high silver concentrations (Fig. 3) 
proper integration of the implant into the bone tissue might be favoured in the absence of silver. To overcome 
these limited biocompatibility of silver containing DLC-coatings we proposed an intelligent surface providing a 
temporary silver burst suitable to prevent the colonization of the implant surface by bacteria peri-surgery and a 
fully mammalian cell compatible surface post-surgery. To verify the temporary release of silver from our DLC 
coatings we applied inductively coupled plasma optical emission spectroscopy (ICP-OES).
The analysis of the silver release kinetics into simulated body fluid showed highly time- and 
concentration-dependent release rates. Independent of the silver content available in the DLC surface, we meas-
ured a high initial silver release in the first 24 hours (Fig. 6a). In comparison to day 1, liberation of silver was 
significantly lower during day 2 and declined further in a linear manner in all tested sample sets. The amount 
of silver liberated from the specimens initially containing 0.9% (sample set D) and 1.7% (sample set C) silver, 
approaches the supposed lower detection limit of the used inductively coupled plasma optical emission spec-
troscopy (ICP-OES) of 0.14 μg/cm2 on day 7 and 9, respectively. The silver release of the DLC coating bearing the 
highest silver concentration (sample set B) decreases to 0.79 μg/cm2 on day 10, which is about 21% of the initial 
value. From a linear extrapolation of the release values of days 2 to 10, one can estimate that the release of this 
sample reaches the lower detection limit on day 20.
Figure 6. Silver release from silver nanoparticles embedded into DLC. (a) Silver release per area over ten 
days in simulated body fluid. (b) Metabolic activity of L929 cells cultivated on indicated specimens. The white 
bar reflects the metabolic activity of L929 cultivated on implants rinsed with water prior to the experiment. 
The metabolic activity of cells grown on tissue culture-treated polystyrene (co) was normalized to 100%, 
background levels of absorbance were subtracted. Data are represented as mean ± SD of at least 3 independent 
experiments. Statistical significant difference (P < 0.01) between the pretreated (B*) and the non-pretreated (B) 
specimens is indicated by the asterisk. Ti = Ti6Al4V alloy; R = Ti6Al4V alloy with diamond-like carbon (DLC); 
B = DLC with 4.5 ± 0.5% silver; C = DLC with 1.7 ± 0.4% silver; D = DLC with 0.9 ± 0.2% silver.
www.nature.com/scientificreports/
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These results indicate that most of the available DLC-associated silver was released from the implant surface 
within the first hours after contact to body fluid. To further prove the biological consequence of the silver release, 
we simulated a peri-surgery release of silver from the DLC by rinsing the implant surface with sterile water prior 
to the dissemination of the silver-sensitive L929 cell. The results shown in Fig. 6b clearly demonstrate an almost 
non-affected growth of the cells on DLC nominally containing 4.5% silver (sample set B*) suggesting a biological 
relevant decay of cytotoxic silver after rinsing (metabolic activity on DLC (sample set R) = 94 ± 10.7%, metabolic 
activity on DLC with 4.5% silver (sample set B) = 14 ± 6.3% and metabolic activity on treated DLC with previ-
ously 4.5% silver (sample set B*) = 63 ± 6.4%) (Fig. 6b).
In summary, our results suggest an early and fast release of the silver from the implant surface and therefore a 
sufficient depression of bacterial vitality only peri-surgery. Additionally, our data indicate that the release of silver 
from the implant produces a biocompatible surface that appears to allow the early settlement of silver-sensitive 
cells already few hours post-surgery.
Conclusion
The purpose of our work was the development of a novel implant coating having antimicrobial properties in 
combination with a high biological compatibility.
Therefore, we applied the previously developed plasma immersion ion implantation (PIII) of silver-polymer 
nanocomposites47 facilitating DLC modifications of three dimensional structures and envisioning also an indus-
trial application. Moreover it is supposed that application of PIII improves the bond between the DLC and the 
implant surface reducing susceptibility to early delaminate due to a poor surface adhesion which is a major reason 
for implant revisions in clinics48.
Antimicrobial properties of DLC-silver composites have been investigated in previous works suggesting a 
useful approach to prevent colonization of bacteria49. In line with that, we could also demonstrate that our silver 
nanoparticle enriched DLC coatings exhibit antimicrobial activities due to the release of silver in a burst-like 
and transient manner, where the degree of toxicities was adjustable through the amount of incorporated silver 
nanoparticles.
In addition we bought into focus the biological compatibility of DLC layers with and without incorporated 
silver in order to evaluate the potential of bony integration. In the past, various in vitro and in vivo studies could 
prove a high biocompatibility of DLC and its potential applicability in several clinical contexts including also 
orthopaedics50,51. Using in vitro settings, mostly growth of fibroblast and osteoblast and activation of monocytes/
macrophages and platelets have been investigated52 while knowledge on endothelial cell growth and activation 
is still limited53. However, biocompatibility in terms of tissue vascularization is essential for the regeneration 
of the wounded bone after placement of a prosthesis as well as relevant for the proper bony integration of the 
implant post-surgery. Moreover, the potential impact of released silver ions on the tissue integration after surgery 
was largely unconsidered in the past prompting us to analyze the influence of silver on human endothelial cells 
regarding their potential to re- and neovascularize the tissue. Although we measured a clear cytotoxicity at high 
silver concentrations we measured that lower, nontoxic concentrations of silver could even promote a proangio-
genic cell phenotype. Therefore, DLC with incorporated silver nanoparticles appears to be a convenient substrate 
that could prevent bacterial colonialization in a short-term and that could actively support tissue regeneration in 
the long-run. A schematic sketch summarizing the basic findings of our study is presented in Fig. 7.
Methods
Surface and material preparation and characterization. Surface and material preparation and char-
acterization is outlined in detail in the supplementary material and elsewhere54.
Figure 7. Schematic sketch of the major concepts of the intelligent implant surface. Early and excessive 
release of silver into the supernatant prevents the growth of bacteria such as S. aureus (peri-surgery). 
Towards the end of the silver burst, low concentrations of silver nanoparticels induce a procoagulatory and a 
proangiogenic status in endothelial cells (early post-surgery). Further cell proliferation and differentiation 
leads to vascularization and to the integration of the implant into the bone (late post-surgery).
www.nature.com/scientificreports/
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Measurement of silver release. Silver release kinetics were measured in phosphate buffered saline (PBS), 
simulating body fluid. The solution contained 8,000 mg/l NaCl, 200 mg/l KCl, 1,150 mg/l Na2HPO4 and 200 mg/l 
KH2PO4 (Dulbecco, Biochrom). For higher silver ion yield, three sample discs of the same silver concentration 
were put into a beaker glass at a time. In order to eliminate edge effects and contributions of the uncoated disc 
bottoms, the samples were embedded in paraffin. 10 ml PBS was added and incubated for 24 hours at 37 °C. 
Afterwards, the fluid was removed and replaced by another 10 ml of PBS. This was repeated for ten days and con-
ducted with five sets of three discs for each concentration of silver in the coating. For comparison, one additional 
set of pure DLC without silver was used.
The incubated PBS solutions were analyzed by inductively coupled plasma optical emission spectroscopy 
(ICP-OES; Vista-MPX, Varian). A 10 μg/ml silver plasma standard solution (Alfa Aesar) was used for calibration.
Antimicrobial activity. Antibacterial properties of the different surfaces were analyzed as previously 
described27,32. Staphylococcus epidermidis (ATCC® 35984TM) and S. aureus (ATCC® 25923TM) were cultured on 
Columbia Agar (CA) with 5% sheep blood (Becton-Dickinson, Heidelberg, Germany) at 37 °C overnight. After 
overnight culture on agar plates bacteria were diluted in Dulbeco’s Modified Eagle Medium (DMEM, life technol-
ogies, Paisley, GB) supplemented with 10% fetal calf serum and adjusted by densitometry with a McFarland 0.5 
standard. Serial dilutions of the final suspension were plated on Columbia Agar with 5% sheep blood for a control 
of the inoculum counts. Surface modified specimens and untreated surfaces were then inoculated with 105 CFU/
ml (colony forming units) of bacteria in DMEM supplemented with 10% FCS for 24 h. Culture conditions were 
comparable for microbiologic and cell culture assays to guarantee the same concentrations of free metal ions in 
the growth medium. After the incubation interval, supernatant was removed and supplemented with a neutraliz-
ing solution to prevent reminiscent toxicity24. CFU were counted visually after 24 hours on CA plates to quantify 
antibacterial efficacy of released metal ions in the supernatant growth medium.
After careful rinsing of the colonized implant specimens to remove excessive bacteria, sonication was per-
formed for 7 minutes (Sonorex RK255H, Bandelin Electronic, Berlin, Germany) in normal saline to remove the 
adhering microorganisms. Again, CFU were quantified on CA plates and after incubation for 24 hours. Complete 
detachment of the adhering microorganisms had been confirmed through scanning electron microscopy (SEM).
Cell culture. L929 cells and THP-1 cells were maintained in RPMI 1640 medium supplemented with 10% 
fetal calf serum (FCS), 1% L-glutamine and 1% penicillin/streptomycin. SAOS-2 cells were grown in McCoy’s 5 
medium with 10% FCS, 1% L-glutamine and 1% penicillin/streptomycin. Primary human osteoblast-like cells25 
were cultured in calcium-free DMEM culture medium supplemented with 10% FCS, 2 mM glutamine, 1% peni-
cillin/streptomycin and MEM-vitamins. Human umbilical vein endothelial cells (HUVEC) were freshly isolated 
from umbilical cord veins and cultivated in M199 medium supplemented with 10% FCS, and 1% growth supple-
ment derived from bovine retina55. All cells were incubated at 37 °C in a humidified atmosphere containing 5% 
CO2.
Mammalian cell activity after surface colonisation. Mitochondrial activity was measured with 
a WST-1 (1[2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium) assay kit (Roche, 
Mannheim, Germany). For the measurement of the intracellular concentrations of ATP, cells were harvested 
from the implant surface and were examined according to the manufacturer’s protocol (Promega, Mannheim, 
Germany).
Scatter light-free structured illumination fluorescence microscopy (ApoTome). Prior to 
ApoTome analyis VWF of HUVEC, grown on implant surfaces, was stained by immunofluorescence as previ-
ously described43. A detailed description is presented in the supplementary material.
Quantification of von Willebrand factor. To quantify the concentration of von Willebrand factor 
(VWF) in the supernatant of HUVEC, we applied Enzyme Linked Immunosorbent Assays (ELISA) as previously 
reported42,56.
Tube formation assay. Tube formation assays were conducted on matrigel plugs polymerized in angio-
genesis cell culture dishes (ibidi, Martinsried, Germany). HUVECs were seeded in serum and growth factor free 
basal medium (EBM-2, Lonza, Cologne, Germany) at a cell concentration of 1 × 104 per well. Where indicated, 
medium was supplemented with VEGF-A (50 ng/ml) or silver nitrate (16 μM, 64 μM, 256μM). Average length of 
tubes was measured after 4 h with a light microscope (Axiovert 100, Zeiss, Oberkochen, Germany).
Statistical analysis. Values were expressed as the mean ± SD and correspond to at least three independent 
experiments. To test statistical significance the unpaired Student’s t-test was used. Results were considered as 
statistically different at P < 0.05.
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